1169768-28-8
1169768-28-8
Chemical Structure
Dlin-MeOH
- CAS No.: 1169768-28-8
- Formula:C37H68O
- Molecular Weight:528.94
IUPAC Name: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazoline
InChIKey: MXYDYSQZZPJVJD-MAZCIEHSSA-N
SMILES: CCCCC/C=C\C/C=C\CCCCCCCCC(O)CCCCCCCC/C=C\C/C=C\CCCCC
Biological Activity: Dlin-MeOH is an intermediate in the synthesis of DLin-MC3-DMA (HY-112251), which serves as an ionizable lipid component of lipid nanoparticles for mRNA delivery[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dlin-MeOH | 99.92% | Dlin-MeOH is an intermediate in the synthesis of DLin-MC3-DMA (HY-112251), which serves as an ionizable lipid component of lipid nanoparticles for mRNA delivery. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Evers MJW, et al. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles. Journal of controlled release : official journal of the Controlled Release Society. 2022 Mar;343:207-216.
- [2]. Biscans A, et al. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo. Journal of controlled release : official journal of the Controlled Release Society. 2022 Sep;349:831-843.
